1型糖尿病中的心血管风险
Cardiovascular risk in type 1 diabetes mellitus.
作者信息
Slim Ines Ben Hadj Slama
机构信息
Department of Endocrinology and Diabetes, Farhat Hached Hospital, Sousse, Tunisia.
出版信息
Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S7-S13. doi: 10.4103/2230-8210.119489.
Abstract
Commonly cardiovascular risk (CVR) is linked to type 2 diabetes mellitus as this type is known to be part of the metabolic syndrome, which includes other cardiovascular factors such as hypertension, dyslipidemia. Inversely, CVR of type 1 diabetes mellitus (T1DM) is currently being debated apart from the occurrence of diabetic nephropathy (DN). For this, we did a review of CVR in patients with T1DM complicated or not with DN. The place of novel non-invasive techniques in screening of subclinical vascular damage is also discussed in this review.
摘要
心血管风险（CVR）通常与2型糖尿病相关，因为已知该型糖尿病是代谢综合征的一部分，代谢综合征还包括其他心血管因素，如高血压、血脂异常。相反，1型糖尿病（T1DM）的CVR目前除了糖尿病肾病（DN）的发生外仍存在争议。为此，我们对合并或未合并DN的T1DM患者的CVR进行了综述。本综述还讨论了新型非侵入性技术在亚临床血管损伤筛查中的作用。
相似文献
1
Cardiovascular risk in type 1 diabetes mellitus.
Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S7-S13. doi: 10.4103/2230-8210.119489.
2
Prevalence of Metabolic Syndrome and Its Risk Factors Influence on Microvascular Complications in Patients With Type 1 and Type 2 Diabetes Mellitus.
Cureus. 2024 Mar 4;16(3):e55478. doi: 10.7759/cureus.55478. eCollection 2024 Mar.
3
Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk.
J Clin Med. 2021 Apr 20;10(8):1798. doi: 10.3390/jcm10081798.
4
Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries.
Am Heart J. 2004 Jun;147(6):1017-23. doi: 10.1016/j.ahj.2003.07.029.
5
Association between diabetic nephropathy and left ventricular longitudinal myocardial function in type 1 diabetes mellitus patients with preserved ejection fraction.
Int J Cardiovasc Imaging. 2022 Sep;38(9):1991-1998. doi: 10.1007/s10554-022-02613-z. Epub 2022 Apr 23.
6
Subclinical macroangiopathic target organ damage in type 1 diabetes mellitus patients.
Blood Press. 2020 Dec;29(6):344-356. doi: 10.1080/08037051.2020.1770054. Epub 2020 May 28.
7
Relationship between serum bilirubin concentrations and diabetic nephropathy in Shanghai Han's patients with type 1 diabetes mellitus.
BMC Nephrol. 2017 Mar 31;18(1):114. doi: 10.1186/s12882-017-0531-8.
8
Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes.
J Diabetes Complications. 2023 Mar;37(3):108414. doi: 10.1016/j.jdiacomp.2023.108414. Epub 2023 Feb 3.
9
Impaired pressure natriuresis and non-dipping blood pressure in rats with early type 1 diabetes mellitus.
J Physiol. 2019 Feb;597(3):767-780. doi: 10.1113/JP277332. Epub 2018 Dec 23.
10
Genetic association between interleukin-10 gene rs1518111 and rs3021094 polymorphisms and risk of type 1 diabetes and diabetic nephropathy in Egyptian children and adolescents.
Pediatr Diabetes. 2021 Jun;22(4):567-576. doi: 10.1111/pedi.13201. Epub 2021 Apr 2.
引用本文的文献
1
Vaccine for Diabetes-Where Do We Stand?
Int J Mol Sci. 2022 Aug 22;23(16):9470. doi: 10.3390/ijms23169470.
2
New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
Int J Mol Sci. 2019 Sep 26;20(19):4789. doi: 10.3390/ijms20194789.
3
Health Benefits of Endurance Training: Implications of the Brain-Derived Neurotrophic Factor-A Systematic Review.
Neural Plast. 2019 Jun 24;2019:5413067. doi: 10.1155/2019/5413067. eCollection 2019.
4
The Role of Allograft Inflammatory Factor-1 in the Effects of Experimental Diabetes on B Cell Functions in the Heart.
Front Cardiovasc Med. 2018 Sep 11;5:126. doi: 10.3389/fcvm.2018.00126. eCollection 2018.
5
As a Versatile Vehicle for Tolerogenic Immunotherapy.
Front Immunol. 2018 Jan 17;8:1961. doi: 10.3389/fimmu.2017.01961. eCollection 2017.
6
Cardiomyocyte GTP Cyclohydrolase 1 Protects the Heart Against Diabetic Cardiomyopathy.
Sci Rep. 2016 Jun 13;6:27925. doi: 10.1038/srep27925.
7
Complex evaluation of left atrial dysfunction in patients with type 1 diabetes mellitus by three-dimensional speckle tracking echocardiography: results from the MAGYAR-Path Study.
Anatol J Cardiol. 2016 Aug;16(8):587-593. doi: 10.5152/AnatolJCardiol.2015.6225. Epub 2015 Nov 25.
8
Long-term improvement of arterial wall characteristics in patients with diabetes mellitus type 1 using cyclic, intermittent treatment with a low-dose fluvastatin and valsartan combination.
Exp Ther Med. 2015 Sep;10(3):1207-1211. doi: 10.3892/etm.2015.2622. Epub 2015 Jul 7.
本文引用的文献
1
Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study.
BMJ. 2011 Sep 8;343:d5364. doi: 10.1136/bmj.d5364.
2
The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus.
Cardiovasc Diabetol. 2011 Jun 16;10:53. doi: 10.1186/1475-2840-10-53.
3
Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.
Diabetes Care. 2011 Apr;34(4):968-74. doi: 10.2337/dc10-1675.
4
All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry.
Diabetes Care. 2010 Dec;33(12):2573-9. doi: 10.2337/dc10-1170.
5
Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients are dependent on age and mean blood pressure.
Exp Clin Endocrinol Diabetes. 2011 May;119(5):281-5. doi: 10.1055/s-0030-1267184. Epub 2010 Oct 28.
6
Evolution and predictors of morphological and functional arterial changes in the course of type 1 diabetes mellitus.
Diabetes Metab Res Rev. 2010 Nov;26(8):646-55. doi: 10.1002/dmrr.1133. Epub 2010 Oct 4.
7
Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes.
Diabetes. 2010 Dec;59(12):3216-22. doi: 10.2337/db10-0862. Epub 2010 Aug 25.
8
Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae?
J Pediatr. 2010 Oct;157(4):540-6. doi: 10.1016/j.jpeds.2010.04.050. Epub 2010 Jun 12.
9
Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.
J Clin Endocrinol Metab. 2010 Feb;95(2):513-21. doi: 10.1210/jc.2009-1756. Epub 2009 Nov 13.
10
Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited.
Diabetologia. 2009 Jan;52(1):42-5. doi: 10.1007/s00125-008-1177-7. Epub 2008 Oct 30.
Zotero 插件